Published in J Proteome Res on March 07, 2012
Developments in the identification of glycan biomarkers for the detection of cancer. Mol Cell Proteomics (2013) 1.12
Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status. Mol Cell Proteomics (2014) 1.11
Defining putative glycan cancer biomarkers by MS. Bioanalysis (2012) 0.99
Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer. J Chromatogr A (2013) 0.95
Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteins. Mol Cell Proteomics (2012) 0.94
Smoking and lung cancer-induced changes in N-glycosylation of blood serum proteins. Glycobiology (2012) 0.92
N-linked glycan profiling of GGTA1/CMAH knockout pigs identifies new potential carbohydrate xenoantigens. Xenotransplantation (2013) 0.91
Analytical glycobiology at high sensitivity: current approaches and directions. Glycoconj J (2012) 0.90
B4GALT family mediates the multidrug resistance of human leukemia cells by regulating the hedgehog pathway and the expression of p-glycoprotein and multidrug resistance-associated protein 1. Cell Death Dis (2013) 0.89
Electrochemical lectin based biosensors as a label-free tool in glycomics. Mikrochim Acta (2012) 0.89
Improving N-glycan coverage using HPLC-MS with electrospray ionization at subambient pressure. Anal Chem (2012) 0.89
Comparative profiling of N-glycans isolated from serum samples of ovarian cancer patients and analyzed by microchip electrophoresis. J Proteome Res (2013) 0.88
Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer. J Gastroenterol (2013) 0.87
Quantitative glycomics strategies. Mol Cell Proteomics (2013) 0.85
Recent trends in analytical and structural glycobiology. Curr Opin Chem Biol (2013) 0.85
Proteomics in cancer biomarkers discovery: challenges and applications. Dis Markers (2015) 0.85
Changes in fucosylation of human seminal IgG and secretory component of IgA in leukocytospermic patients. Glycoconj J (2013) 0.84
Evaluation of riproximin binding properties reveals a novel mechanism for cellular targeting. J Biol Chem (2012) 0.83
The Serum Immunoglobulin G Glycosylation Signature of Gastric Cancer. EuPA Open Proteom (2015) 0.83
Discovery of specific metastasis-related N-glycan alterations in epithelial ovarian cancer based on quantitative glycomics. PLoS One (2014) 0.83
Mass spectrometry-based analysis of glycoproteins and its clinical applications in cancer biomarker discovery. Clin Proteomics (2014) 0.83
Enrichment strategies in glycomics-based lung cancer biomarker development. Proteomics Clin Appl (2013) 0.82
Evaluation of glycomic profiling as a diagnostic biomarker for epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2014) 0.82
Isolation and purification of glycoconjugates from complex biological sources by recycling high-performance liquid chromatography. Anal Chem (2013) 0.82
N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues. Mol Cell Proteomics (2016) 0.80
Examination of glycan profiles from IgG-depleted human immunoglobulins facilitated by microscale affinity chromatography. Anal Chem (2012) 0.79
The serum glycome to discriminate between early-stage epithelial ovarian cancer and benign ovarian diseases. Dis Markers (2014) 0.79
Glycans and glycoproteins as specific biomarkers for cancer. Anal Bioanal Chem (2016) 0.79
Glycosylation of plasma IgG in colorectal cancer prognosis. Sci Rep (2016) 0.79
Complementary Glycomic Analyses of Sera Derived from Colorectal Cancer Patients by MALDI-TOF-MS and Microchip Electrophoresis. Anal Chem (2016) 0.78
LC-MS/MS analysis of permethylated free oligosaccharides and N-glycans derived from human, bovine, and goat milk samples. Electrophoresis (2016) 0.78
Integrin receptors on tumor cells facilitate NK cell-mediated antibody-dependent cytotoxicity. Eur J Immunol (2014) 0.78
Recent Advances in the Analysis of Complex Glycoproteins. Anal Chem (2016) 0.77
Increased sialylation of anti-Thomsen-Friedenreich antigen (CD176) antibodies in patients with gastric cancer: a diagnostic and prognostic potential. Biomed Res Int (2014) 0.77
Sub 2-μm macroporous silica particles derivatized for enhanced lectin affinity enrichment of glycoproteins. Anal Chem (2013) 0.77
Quantitation of permethylated N-glycans through multiple-reaction monitoring (MRM) LC-MS/MS. J Am Soc Mass Spectrom (2015) 0.77
Structural Characterization of Serum N-Glycans by Methylamidation, Fluorescent Labeling, and Analysis by Microchip Electrophoresis. Anal Chem (2016) 0.77
Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer. Epigenetics (2016) 0.76
Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer. Dis Markers (2015) 0.76
Applications of Multiple Reaction Monitoring to Clinical Glycomics. Chromatographia (2015) 0.76
High-temperature LC-MS/MS of permethylated glycans derived from glycoproteins. Electrophoresis (2016) 0.76
Purification of derivatized oligosaccharides by solid phase extraction for glycomic analysis. PLoS One (2014) 0.76
Protein-Specific Differential Glycosylation of Immunoglobulins in Serum of Ovarian Cancer Patients. J Proteome Res (2016) 0.76
Serum N-glycome characterization and anti-carbohydrate antibody profiling in oral squamous cell carcinoma patients. PLoS One (2017) 0.75
Glycomic expression in esophageal disease. Metabolites (2012) 0.75
Serum glycoprotein-derived N- and O-linked glycans as cancer biomarkers. Am J Cancer Res (2016) 0.75
Polysialylated N-glycans identified in human serum through combined developments in sample preparation, separations, and electrospray ionization-mass spectrometry. Anal Chem (2014) 0.75
Simultaneous analyses of N-linked and O-linked glycans of ovarian cancer cells using solid-phase chemoenzymatic method. Clin Proteomics (2017) 0.75
Discovery of Non-invasive Glycan Biomarkers for Detection and Surveillance of Gastric Cancer. J Cancer (2017) 0.75
Characterization of isomeric glycan structures by LC-MS/MS. Electrophoresis (2017) 0.75
Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome. Oncotarget (2017) 0.75
Lectin array and glycogene expression analyses of ovarian cancer cell line A2780 and its cisplatin-resistant derivate cell line A2780-cp. Clin Proteomics (2017) 0.75
Measuring the accuracy of diagnostic systems. Science (1988) 27.46
The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics (2002) 16.08
Biological roles of oligosaccharides: all of the theories are correct. Glycobiology (1993) 12.38
Glycosylation in cellular mechanisms of health and disease. Cell (2006) 8.45
Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci U S A (2004) 7.55
Glycans in cancer and inflammation--potential for therapeutics and diagnostics. Nat Rev Drug Discov (2005) 6.14
The CA 125 tumour-associated antigen: a review of the literature. Hum Reprod (1989) 4.13
Serum protein markers for early detection of ovarian cancer. Proc Natl Acad Sci U S A (2005) 3.22
Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. J Proteome Res (2006) 2.99
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res (2004) 2.96
New tumor markers: CA125 and beyond. Int J Gynecol Cancer (2005) 2.92
Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology (2007) 2.45
Alterations in the serum glycome due to metastatic prostate cancer. J Proteome Res (2007) 2.30
Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med (2004) 2.29
Solid-phase permethylation of glycans for mass spectrometric analysis. Rapid Commun Mass Spectrom (2005) 2.27
Characterization of serum biomarkers for detection of early stage ovarian cancer. Proteomics (2005) 2.06
Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Clin Chem (2008) 1.96
Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics (2008) 1.94
The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays. Mol Cell Proteomics (2009) 1.77
Early detection of ovarian cancer. Dis Markers (2007) 1.77
Alterations in glycosylation as biomarkers for cancer detection. J Clin Pathol (2010) 1.73
Mass spectrometry based glycoproteomics--from a proteomics perspective. Mol Cell Proteomics (2010) 1.55
A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology (2008) 1.55
Plasma proteomic pattern as biomarkers for ovarian cancer. Int J Gynecol Cancer (2006) 1.53
Bead-based ELISA for validation of ovarian cancer early detection markers. Clin Cancer Res (2006) 1.52
Detection of hepatocellular carcinoma using glycomic analysis. Clin Cancer Res (2009) 1.52
Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery. Anal Chem (2010) 1.47
Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects. Int J Cancer (2008) 1.33
Novel glycan biomarkers for the detection of lung cancer. J Proteome Res (2011) 1.33
Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis. Dis Markers (2008) 1.27
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use. Int J Gynecol Cancer (2005) 1.26
Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease onsets. J Proteome Res (2009) 1.25
ProteinQuant Suite: a bundle of automated software tools for label-free quantitative proteomics. Rapid Commun Mass Spectrom (2008) 1.24
Identification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in-gel electrophoresis. Electrophoresis (2010) 1.19
Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer. Clin Cancer Res (2004) 1.18
Focused glycomic analysis of the N-linked glycan biosynthetic pathway in ovarian cancer. Proteomics (2008) 1.17
Glycomics analysis of serum: a potential new biomarker for ovarian cancer? Int J Gynecol Cancer (2007) 1.16
Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis. Proteomics (2010) 1.16
Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer. J Proteome Res (2011) 1.14
Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer. Cancer (2007) 1.11
Diagnostic value of the hemopexin N-glycan profile in hepatocellular carcinoma patients. Clin Chem (2010) 1.09
ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand. J Immunol Methods (2008) 1.09
Elevated levels of abnormally-fucosylated haptoglobins in cancer sera. Br J Cancer (1987) 1.08
Presence of aberrant tumor-reactive immunoglobulins in the circulation of patients with ovarian cancer. Gynecol Oncol (2001) 1.07
Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation. J Biochem (2000) 1.03
Altered glycosylation of serum transferrin of patients with hepatocellular carcinoma. J Biol Chem (1989) 1.03
Glycoproteomic analyses of ovarian cancer cell lines and sera from ovarian cancer patients show distinct glycosylation changes in individual proteins. J Proteome Res (2008) 1.02
Role of serum matrix metalloproteinase-2 and -9 to predict breast cancer progression. Clin Biochem (2011) 1.00
Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancer. Cancer Lett (1992) 0.98
Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer. Cancer (2011) 0.98
Identification of N-glycan of alpha-fetoprotein by lectin affinity microarray. J Cancer Res Clin Oncol (2008) 0.97
N-glycosylation status of beta-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects. Int J Cancer (2010) 0.93
Changes in serum IgG oligosaccharide chains with prostate cancer progression. Anticancer Res (2004) 0.92
Glycoforms of CA125 antigen as a possible cancer marker. Cancer Biomark (2008) 0.92
Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array. Int J Cancer (2011) 0.92
N-glycomic changes in human breast carcinoma MCF-7 and T-lymphoblastoid cells after treatment with herceptin and herceptin/Lipoplex. J Proteome Res (2010) 0.91
Glycan array: a powerful tool for glycomics studies. Expert Rev Proteomics (2009) 0.91
Interleukin-1beta induces sialyl Lewis X on hepatocellular carcinoma HuH-7 cells via enhanced expression of ST3Gal IV and FUT VI gene. FEBS Lett (2006) 0.90
Alteration of sugar chains on alpha(1)-acid glycoprotein secreted following cytokine stimulation of HuH-7 cells in vitro. Clin Chim Acta (2000) 0.87
Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer. Gynecol Oncol (2005) 0.84
Glycomic Alterations in the Highly-abundant and Lesser-abundant Blood Serum Protein Fractions for Patients Diagnosed with Hepatocellular Carcinoma. Int J Mass Spectrom (2011) 0.83
Human immunoglobulin glycosylation and the lectin pathway of complement activation. Adv Exp Med Biol (2005) 0.82
Protein arrays for biomarker discovery. Curr Opin Mol Ther (2007) 0.80
Comparison of the methods for profiling glycoprotein glycans--HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology (2007) 2.71
A computational approach toward label-free protein quantification using predicted peptide detectability. Bioinformatics (2006) 2.48
Alterations in the serum glycome due to metastatic prostate cancer. J Proteome Res (2007) 2.30
Solid-phase permethylation of glycans for mass spectrometric analysis. Rapid Commun Mass Spectrom (2005) 2.27
Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Clin Chem (2008) 1.96
Structural investigations of glycoconjugates at high sensitivity. Chem Rev (2002) 1.79
High-throughput solid-phase permethylation of glycans prior to mass spectrometry. Rapid Commun Mass Spectrom (2008) 1.74
Individual and gender fingerprints in human body odour. J R Soc Interface (2007) 1.65
Characterization of glycopeptides by combining collision-induced dissociation and electron-transfer dissociation mass spectrometry data. Rapid Commun Mass Spectrom (2009) 1.60
Altered expression of organic anion transporter polypeptide (OATP) genes in human breast carcinoma. Cancer Biol Ther (2008) 1.59
Development of high-sensitivity ion trap ion mobility spectrometry time-of-flight techniques: a high-throughput nano-LC-IMS-TOF separation of peptides arising from a Drosophila protein extract. Anal Chem (2003) 1.54
Microextraction of bacterial lipid A: easy and rapid method for mass spectrometric characterization. J Lipid Res (2005) 1.53
Detection of hepatocellular carcinoma using glycomic analysis. Clin Cancer Res (2009) 1.52
Minireview: epigenetic changes in ovarian cancer. Endocrinology (2009) 1.49
Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery. Anal Chem (2010) 1.47
Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1. Mol Cell Proteomics (2009) 1.45
Retracted Regenerated oxidized cellulose reinforcement of low rectal anastomosis: do we still need diversion? Dis Colon Rectum (2010) 1.45
Pheromone binding by polymorphic mouse major urinary proteins. Protein Sci (2002) 1.39
Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics Assessment. PLoS One (2015) 1.38
Resolving and assigning N-linked glycan structural isomers from ovalbumin by IMS-MS. J Am Soc Mass Spectrom (2008) 1.37
A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer. Cancer (2010) 1.34
Structural characterization of oligosaccharides using MALDI-TOF/TOF tandem mass spectrometry. Anal Chem (2003) 1.27
Comparative glycomic mapping through quantitative permethylation and stable-isotope labeling. Anal Chem (2007) 1.26
Electrophoretic analysis of N-glycans on microfluidic devices. Anal Chem (2007) 1.26
Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease onsets. J Proteome Res (2009) 1.25
Glycomic profiling of invasive and non-invasive breast cancer cells. Glycoconj J (2008) 1.24
ProteinQuant Suite: a bundle of automated software tools for label-free quantitative proteomics. Rapid Commun Mass Spectrom (2008) 1.24
High-sensitivity analytical approaches for the structural characterization of glycoproteins. Chem Rev (2013) 1.23
Solid-phase permethylation for glycomic analysis. Methods Mol Biol (2009) 1.21
Hypermethylation of 18S and 28S ribosomal DNAs predicts progression-free survival in patients with ovarian cancer. Clin Cancer Res (2005) 1.20
Identifying cancer biomarkers by mass spectrometry-based glycomics. Electrophoresis (2012) 1.19
A proteomic survey of rat cerebral cortical synaptosomes. Proteomics (2005) 1.16
Clock genes display rhythmic expression in human hearts. Chronobiol Int (2009) 1.16
Characterizing protein glycosylation sites through higher-energy C-trap dissociation. Rapid Commun Mass Spectrom (2010) 1.16
Investigation of the possible biological activities of a poisonous South African plant; Hyaenanche globosa (Euphorbiaceae). Pharmacogn Mag (2010) 1.15
Advancement in protein inference from shotgun proteomics using peptide detectability. Pac Symp Biocomput (2007) 1.15
A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker. Proc Natl Acad Sci U S A (2006) 1.13
Glycomic analysis of sialic acid linkages in glycans derived from blood serum glycoproteins. J Proteome Res (2010) 1.13
The discovery of labile methyl esters on proliferating cell nuclear antigen by MS/MS. Proteomics (2006) 1.12
Application of dissimilarity indices, principal coordinates analysis, and rank tests to peak tables in metabolomics of the gas chromatography/mass spectrometry of human sweat. Anal Chem (2007) 1.12
Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma. J Proteome Res (2008) 1.12
Automated interpretation of MS/MS spectra of oligosaccharides. Bioinformatics (2005) 1.12
Combining lectin microcolumns with high-resolution separation techniques for enrichment of glycoproteins and glycopeptides. Anal Chem (2005) 1.11
Improving confidence in detection and characterization of protein N-glycosylation sites and microheterogeneity. Rapid Commun Mass Spectrom (2011) 1.10
Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data. J Proteome Res (2010) 1.10
Efficacy of glycoprotein enrichment by microscale lectin affinity chromatography. J Sep Sci (2008) 1.08
LC-MS profiling of N-Glycans derived from human serum samples for biomarker discovery in hepatocellular carcinoma. J Proteome Res (2014) 1.08
A monolithic PNGase F enzyme microreactor enabling glycan mass mapping of glycoproteins by mass spectrometry. Rapid Commun Mass Spectrom (2005) 1.06
Miniaturized separation techniques in glycomic investigations. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 1.06
Thermodynamic consequences of disrupting a water-mediated hydrogen bond network in a protein:pheromone complex. Protein Sci (2005) 1.06
Comparing MALDI-MS, RP-LC-MALDI-MS and RP-LC-ESI-MS glycomic profiles of permethylated N-glycans derived from model glycoproteins and human blood serum. Electrophoresis (2012) 1.06
Songbird chemosignals: volatile compounds in preen gland secretions vary among individuals, sexes, and populations. Behav Ecol (2010) 1.05
Hedgehog-producing cancer cells respond to and require autocrine Hedgehog activity. Cancer Res (2011) 1.05
Activation-induced cytidine deaminase (AID) linking immunity, chronic inflammation, and cancer. Cancer Immunol Immunother (2012) 1.05
Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012. Mol Cell Proteomics (2013) 1.03
Multimethodological approach to identification of glycoproteins from the proteome of Francisella tularensis, an intracellular microorganism. J Proteome Res (2010) 1.03
Seasonal variation in volatile compound profiles of preen gland secretions of the dark-eyed junco (Junco hyemalis). J Chem Ecol (2007) 1.02
New hyphenated methodologies in high-sensitivity glycoprotein analysis. J Sep Sci (2005) 1.02
High-sensitivity profiling of glycoproteins from human blood serum through multiple-lectin affinity chromatography and liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 1.02
Computational framework for identification of intact glycopeptides in complex samples. Anal Chem (2013) 1.01
Thermodynamic analysis of binding between mouse major urinary protein-I and the pheromone 2-sec-butyl-4,5-dihydrothiazole. Biochemistry (2003) 1.01
The Kinesin-related protein Costal2 associates with membranes in a Hedgehog-sensitive, Smoothened-independent manner. J Biol Chem (2003) 1.00
Enhanced sensitivity of LC-MS analysis of permethylated N-glycans through online purification. Electrophoresis (2011) 0.99
Urinary bladder catheter drainage following pelvic surgery--is it necessary for that long? Dis Colon Rectum (2010) 0.99
Defining putative glycan cancer biomarkers by MS. Bioanalysis (2012) 0.99
Chemotaxis assays of mouse sperm on microfluidic devices. Anal Chem (2006) 0.98
Analysis of site-specific glycosylation of renal and hepatic γ-glutamyl transpeptidase from normal human tissue. J Biol Chem (2010) 0.98
Tumor-specific expression of organic anion-transporting polypeptides: transporters as novel targets for cancer therapy. J Drug Deliv (2013) 0.98
PDGF BB induces VEGF secretion in ovarian cancer. Cancer Biol Ther (2007) 0.97
Identification of isomeric N-glycan structures by mass spectrometry with 157 nm laser-induced photofragmentation. J Am Soc Mass Spectrom (2008) 0.97